The Patriot Post® · FDA Shamefully Inaccurate With Abortion Pill Risks

Last year, when the Supreme Court ruled in favor of chemical abortion pills crossing state lines, it opened a can of worms. More children die from abortion drugs than procedures, and mothers are left to face the consequences alone in the privacy of their own homes.

This is a tragic situation, but women see chemical abortions as a low-risk way to get rid of an unwanted pregnancy. Part of this belief is based on sugar-coated claims from the Federal Drug Administration (FDA). But what if those claims are grossly incorrect and the risks are much greater?

Well, according to a study conducted by the Ethics and Public Policy Center (EPPC), the rate of women needing to be hospitalized after taking mifepristone — the abortion pill — is 11%. The potential risks to the mother are “sepsis, infection, hemorrhaging, or another serious adverse event within 45 days following a mifepristone abortion.”

The FDA states that the risk is only 0.5%. The reason for this disparity is that the FDA samples are not as large or accurate. The EPPC says:

Danco Laboratories markets Mifeprex as “the safe and effective abortion pill,” but our research shows that mifepristone abortion, as currently practiced in the U.S., is not safe and effective. The manufacturer and the FDA rely on the results of 10 clinical trials with a total of 30,966 participants, less than 0.5 percent of whom reportedly experienced serious adverse reactions. In contrast, we analyzed real-world insurance claims data for 865,727 prescribed mifepristone abortions, broadly representative of women who obtain mifepristone abortions in the U.S. today, and we find a serious adverse event rate of 10.93 percent — at least 22 times as high as the summary figure reported on the drug label.

That is extremely alarming. More and more women are going to suffer from these dangerous side effects as well because it’s insanely easy to access the drug. As National Review’s Alexandra DeSanctis elaborates, “Under the Biden administration, the FDA loosened its safety protocols to permit women to obtain chemical-abortion drugs without ever seeing a physician in person, or even without consulting a physician at all. … Women can now obtain chemical abortions via telemedicine and the mail, as well as from any ‘certified prescriber,’ a category that includes non-physicians such as physician assistants.”

Remember when ghoulish activists tried to rally the women’s vote for Kamala Harris in Georgia by selling the lie that lack of access to an abortion clinic caused the death of a Georgia woman? It turns out that the mother died because of sepsis brought on by taking an abortion pill. Lack of access isn’t the problem. Lack of care for pregnant women and their preborn children is.

Taking a chemical abortion pill is far more dangerous than aspirin, unlike what advertisers would have women believe. Chemical abortions are obviously deadly to preborn babies, but they are also hazardous to pregnant mothers.